Download to read offline
More Related Content
Similar to NACS Wave 2, Learning Session 3
NACS Wave 2, Learning Session 3
- 1. New Approach toControlling Superbugs Virtual Learning Session 3 Data – Measuring Progress Michael Gardam Leah Gitterman
- 2. Interacting in WebEx Jan28, 2015 2 Be prepared to use: •Pointer •Raise your hand
- 4. Agenda: 1. Welcome andIntroductions 2. Quick poll 3. Why Measure 4. Types of Measures 5. The NACS Measurement Buffet 6. Getting started with the SHN! measures
- 5.
- 6. Why Measure? • Toestablish benchmarks • To monitor compliance with policies and procedures • To understand the impact/efficacy of your interventions • Motivation
- 7. Types of Measures Process: •Measure how people do things • Most done by auditing or observation • Purpose is to verify that health care providers are following procedures • E.g. donning and doffing PPE, environmental cleaning
- 8. Types of Measures Outcome: •Measure the impact of what people do • For example: number of surgical site infections, number of residents acquiring an antibiotic resistant organism
- 9. Measure what thefront line thinks is important What to Measure
- 10. • Measure thethings that provide value for your setting Ask yourself? • Is the information relevant? Will gathering data add value? • Can this process or outcome be measured? • Can the data be fed back to frontline staff in a way that makes sense to them?
- 11. Whatever is beingmeasured, it is important to use the information gathered. Continually review the data and develop action plans to address any issues
- 12. The Measurement Buffet ProcessMeasures • Volume of ABHR used • Volume of soap used • Number of gowns, boxes of gloves used
- 13. Process Measures • %of eligible admissions screened for MRSA • % of eligible admissions screened for VRE • Hand hygiene compliance
- 14. Process Measures Continued… •% of bed spaces where ABHR is readily available, full, easy to activate • % high touch areas in patient environment where there was appropriate cleaning as demonstrated by using a fluorescent marker
- 15. Process Measures Continued… •Reduction in mean time to placement on contact precautions (for known patients and from time of lab notification)
- 16. Outcome Measures • Surveillancefor new healthcare associated MRSA clinical isolates • Surveillance for new healthcare associated VRE clinical isolates • Surveillance for new cases of healthcare associated C. difficile infection
- 17. Getting Started • Takea critical look at your setting • Identify the data you need to collect • Get help • Choose a time period • Review data/analyze information • Share data with the frontline
- 18. Combined nosocomial MRSA,C.diff and VRE rate, 8A, 2005-2010 0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 Jan- Mar 05 Apr- Jun 05 Jul- Sep 05 Oct- Dec 05 Jan- Mar 06 Apr- Jun 06 Jul- Sep 06 Oct- Dec 06 Jan- Mar 07 Apr- Jun 07 Jul- Sep 07 Oct- Dec 07 Jan- Mar 08 Apr- Jun 08 Jul- Sep 08 Oct- Dec 08 Jan- Mar 09 Apr- Jun 09 Jul- Sep 09 Oct- Dec 09 Jan- Mar 10 Apr- Jun 10 Jul- Sep 10 Quarter Rateper1,000ptdays
- 19. 8A Glove andSanitizer Use with Overall HH Compliance 0 10 20 30 40 50 60 08/09 Q1 09/10 Q2 09/10 Q3 09/10 Q4 09/10 Q1 10/11 Q2 10/11 Purchasedunitsper100ptdays 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% %Handhygienecompliance 8A Glove use 8A Sanitizer use 8A HH Compliance
- 20. Combined nosocomial MRSA,C.diff and VRE rate, 9A, 2005-2010 0.0 1.0 2.0 3.0 Jan- Mar 05 Apr- Jun 05 Jul- Sep 05 Oct- Dec 05 Jan- Mar 06 Apr- Jun 06 Jul- Sep 06 Oct- Dec 06 Jan- Mar 07 Apr- Jun 07 Jul- Sep 07 Oct- Dec 07 Jan- Mar 08 Apr- Jun 08 Jul- Sep 08 Oct- Dec 08 Jan- Mar 09 Apr- Jun 09 Jul- Sep 09 Oct- Dec 09 Jan- Mar 10 Apr- Jun 10 Jul- Sep 10 Quarter Rateper1,000ptdays
- 21. 9A Glove andSanitizer Use with Overall HH Compliance 0 10 20 30 40 50 60 08/09 Q1 09/10 Q2 09/10 Q3 09/10 Q4 09/10 Q1 10/11 Q2 10/11 Purchasedunitsper100ptdays 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% %Handhygienecompliance 9A Glove use 9A Sanitizer use 9A HH Compliance
- 22.
- 23. Safety Calendar: AKABug Tracker
- 24.
- 25.
- 26.
- 27. 27 Legend RN External Clinical Educator Allied Health Director ICP Admin Housekeeping MD Executive Volunteer Resources Ward Clerk Patient Education ManagerToday, who do you talk to about the prevention of superbugs? Who do you talk to about the prevention of superbugs?
- 28. 28 Legend RN External Clinical Educator Allied Health Director ICP Admin Housekeeping MD Executive Volunteer Resources Ward Clerk Patient Education ManagerWith whom would you like to work with in the future that you haven’t in past superbug prevention work Who do you want to work with in the future?
- 29. • Keep alog of all PD activities • Access the worksheets here: http://www.saferhealthcarenow.ca/en/interventions/aro_mrsa/pages/measurement.aspx Home » Interventions » NACS » Measurement Worksheets
- 30. www.stopsuperbugs.com Next Learning Session: December6, 2010 Wave 3 starts: January 10, 2011
Editor's Notes
- #3 Mention: how to raise hand for question Annotation Arrow Emoticons
- #7 Solutions before our eyes What enables people to find these solutions? Findings are accessible to all
- #8 Solutions before our eyes What enables people to find these solutions? Findings are accessible to all
- #9 Solutions before our eyes What enables people to find these solutions? Findings are accessible to all
- #11 Solutions before our eyes What enables people to find these solutions? Findings are accessible to all
- #12 Solutions before our eyes What enables people to find these solutions? Findings are accessible to all
- #28 Geralyne removed from this one If on fringes probably didn’t answer survey-they were named but didn’t answer the survey
- #29 Geralyne removed from this one